

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of fibrinolysis (GO:0051918) | 5.66476514 |
| 2 | regulation of protein activation cascade (GO:2000257) | 5.60325773 |
| 3 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.55869375 |
| 4 | regulation of complement activation (GO:0030449) | 5.46406242 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.16944405 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.16944405 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.16944405 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 5.16944405 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 5.16944405 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.16944405 |
| 11 | regulation of fibrinolysis (GO:0051917) | 5.08210715 |
| 12 | cholesterol efflux (GO:0033344) | 4.95246251 |
| 13 | positive regulation of B cell differentiation (GO:0045579) | 4.93315751 |
| 14 | regulation of cholesterol esterification (GO:0010872) | 4.79421898 |
| 15 | phospholipid efflux (GO:0033700) | 4.66257463 |
| 16 | plasma lipoprotein particle organization (GO:0071827) | 4.60136314 |
| 17 | plasma lipoprotein particle remodeling (GO:0034369) | 4.59940383 |
| 18 | protein-lipid complex remodeling (GO:0034368) | 4.59940383 |
| 19 | macromolecular complex remodeling (GO:0034367) | 4.59940383 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 4.59354106 |
| 21 | intestinal cholesterol absorption (GO:0030299) | 4.42914556 |
| 22 | low-density lipoprotein particle remodeling (GO:0034374) | 4.37869897 |
| 23 | protein-lipid complex subunit organization (GO:0071825) | 4.36183822 |
| 24 | neutrophil mediated immunity (GO:0002446) | 4.12997018 |
| 25 | reverse cholesterol transport (GO:0043691) | 4.09022673 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.04578979 |
| 27 | negative regulation of protein activation cascade (GO:2000258) | 4.03306294 |
| 28 | phospholipid homeostasis (GO:0055091) | 4.02982683 |
| 29 | regulation of sequestering of triglyceride (GO:0010889) | 4.02517135 |
| 30 | negative regulation of granulocyte differentiation (GO:0030853) | 4.01029279 |
| 31 | blood coagulation, intrinsic pathway (GO:0007597) | 3.97159715 |
| 32 | diacylglycerol metabolic process (GO:0046339) | 3.96963538 |
| 33 | regulation of cholesterol homeostasis (GO:2000188) | 3.89386514 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.84838562 |
| 35 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.81631827 |
| 36 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.79124556 |
| 37 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.79124556 |
| 38 | pinocytosis (GO:0006907) | 3.78465557 |
| 39 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.77885277 |
| 40 | L-phenylalanine catabolic process (GO:0006559) | 3.77885277 |
| 41 | negative regulation of cholesterol transport (GO:0032375) | 3.74297011 |
| 42 | negative regulation of sterol transport (GO:0032372) | 3.74297011 |
| 43 | histone H3-K36 demethylation (GO:0070544) | 3.66069867 |
| 44 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.64391118 |
| 45 | negative regulation of phagocytosis (GO:0050765) | 3.63241531 |
| 46 | regulation of humoral immune response (GO:0002920) | 3.58727836 |
| 47 | alpha-linolenic acid metabolic process (GO:0036109) | 3.57767114 |
| 48 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.55836643 |
| 49 | L-phenylalanine metabolic process (GO:0006558) | 3.55836643 |
| 50 | histone H3-K9 demethylation (GO:0033169) | 3.54217427 |
| 51 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.52768110 |
| 52 | macrophage activation involved in immune response (GO:0002281) | 3.47040068 |
| 53 | lipoprotein transport (GO:0042953) | 3.47029240 |
| 54 | low-density lipoprotein particle clearance (GO:0034383) | 3.46706621 |
| 55 | acute-phase response (GO:0006953) | 3.44816600 |
| 56 | response to host immune response (GO:0052572) | 3.40856456 |
| 57 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.40856456 |
| 58 | fatty acid transmembrane transport (GO:1902001) | 3.40127538 |
| 59 | histone H3-K4 trimethylation (GO:0080182) | 3.37634743 |
| 60 | response to host defenses (GO:0052200) | 3.34125364 |
| 61 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.34125364 |
| 62 | response to host (GO:0075136) | 3.34125364 |
| 63 | response to muramyl dipeptide (GO:0032495) | 3.30234727 |
| 64 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.26408187 |
| 65 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.26408187 |
| 66 | regulation of cholesterol storage (GO:0010885) | 3.25604702 |
| 67 | negative regulation of complement activation (GO:0045916) | 3.23914832 |
| 68 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.23353405 |
| 69 | triglyceride homeostasis (GO:0070328) | 3.21750518 |
| 70 | acylglycerol homeostasis (GO:0055090) | 3.21750518 |
| 71 | lipoprotein metabolic process (GO:0042157) | 3.20219048 |
| 72 | carnitine shuttle (GO:0006853) | 3.19382088 |
| 73 | cholesterol homeostasis (GO:0042632) | 3.16613423 |
| 74 | protein activation cascade (GO:0072376) | 3.16162969 |
| 75 | regulation of triglyceride catabolic process (GO:0010896) | 3.13812812 |
| 76 | regulation of plasminogen activation (GO:0010755) | 3.12516673 |
| 77 | sterol homeostasis (GO:0055092) | 3.12163613 |
| 78 | germinal center formation (GO:0002467) | 3.07177649 |
| 79 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.06882175 |
| 80 | mannose metabolic process (GO:0006013) | 3.04942801 |
| 81 | necroptotic process (GO:0070266) | 3.04206893 |
| 82 | positive regulation of interferon-alpha production (GO:0032727) | 3.03292673 |
| 83 | negative regulation of lipase activity (GO:0060192) | 3.01079616 |
| 84 | intestinal absorption (GO:0050892) | 3.00885366 |
| 85 | sterol transport (GO:0015918) | 2.99246208 |
| 86 | cholesterol transport (GO:0030301) | 2.99246208 |
| 87 | myeloid leukocyte mediated immunity (GO:0002444) | 2.98783283 |
| 88 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.98416644 |
| 89 | regulation of B cell differentiation (GO:0045577) | 2.98316838 |
| 90 | regulation of cholesterol metabolic process (GO:0090181) | 2.97829133 |
| 91 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.96110065 |
| 92 | positive regulation of histone deacetylation (GO:0031065) | 2.95644048 |
| 93 | valine metabolic process (GO:0006573) | 2.95200794 |
| 94 | immunoglobulin mediated immune response (GO:0016064) | 2.94787565 |
| 95 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.94478578 |
| 96 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.94071642 |
| 97 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.94071642 |
| 98 | positive regulation of steroid metabolic process (GO:0045940) | 2.93769769 |
| 99 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.90406341 |
| 100 | negative regulation of humoral immune response (GO:0002921) | 2.89817948 |
| 101 | plasma lipoprotein particle clearance (GO:0034381) | 2.88902732 |
| 102 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.88598613 |
| 103 | detection of molecule of bacterial origin (GO:0032490) | 2.86517365 |
| 104 | negative regulation of digestive system process (GO:0060457) | 2.85895881 |
| 105 | complement activation, classical pathway (GO:0006958) | 2.85781667 |
| 106 | imidazole-containing compound metabolic process (GO:0052803) | 2.81651037 |
| 107 | regulation of interferon-alpha production (GO:0032647) | 2.81377636 |
| 108 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.81163650 |
| 109 | positive regulation of blood coagulation (GO:0030194) | 2.80761962 |
| 110 | positive regulation of hemostasis (GO:1900048) | 2.80761962 |
| 111 | cellular extravasation (GO:0045123) | 2.80515678 |
| 112 | positive regulation of extracellular matrix organization (GO:1903055) | 2.80189050 |
| 113 | lipid homeostasis (GO:0055088) | 2.78530901 |
| 114 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.76692249 |
| 115 | B cell homeostasis (GO:0001782) | 2.76573219 |
| 116 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.76425126 |
| 117 | carnitine transmembrane transport (GO:1902603) | 2.76103704 |
| 118 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.76037647 |
| 119 | myeloid cell activation involved in immune response (GO:0002275) | 2.74841399 |
| 120 | neutrophil activation involved in immune response (GO:0002283) | 2.74782525 |
| 121 | negative regulation of lipid storage (GO:0010888) | 2.74671162 |
| 122 | glutamate metabolic process (GO:0006536) | 2.72868412 |
| 123 | mitotic sister chromatid cohesion (GO:0007064) | 2.72515500 |
| 124 | regulation of bile acid biosynthetic process (GO:0070857) | 2.71776339 |
| 125 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.70972623 |
| 126 | urea cycle (GO:0000050) | 2.69752963 |
| 127 | urea metabolic process (GO:0019627) | 2.69752963 |
| 128 | embryonic process involved in female pregnancy (GO:0060136) | 2.69293506 |
| 129 | microglial cell activation (GO:0001774) | 2.68805744 |
| 130 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.68778428 |
| 131 | plasma lipoprotein particle assembly (GO:0034377) | 2.68752974 |
| 132 | complement activation (GO:0006956) | 2.68397126 |
| 133 | proline metabolic process (GO:0006560) | 2.68289877 |
| 134 | complement activation, alternative pathway (GO:0006957) | 2.66530894 |
| 135 | histone lysine demethylation (GO:0070076) | 2.64209219 |
| 136 | regulation of phagocytosis (GO:0050764) | 2.63104155 |
| 137 | regulation of granulocyte differentiation (GO:0030852) | 2.61325462 |
| 138 | positive regulation of hormone metabolic process (GO:0032352) | 2.60509723 |
| 139 | nitrogen cycle metabolic process (GO:0071941) | 2.59328935 |
| 140 | ethanol oxidation (GO:0006069) | 2.59246315 |
| 141 | oligosaccharide catabolic process (GO:0009313) | 2.59225264 |
| 142 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.59164003 |
| 143 | positive regulation of coagulation (GO:0050820) | 2.59143775 |
| 144 | negative regulation of fatty acid transport (GO:2000192) | 2.57704424 |
| 145 | regulation of gamma-delta T cell activation (GO:0046643) | 2.57569902 |
| 146 | fibrinolysis (GO:0042730) | 2.57324813 |
| 147 | protein localization to kinetochore (GO:0034501) | 2.57001790 |
| 148 | pore complex assembly (GO:0046931) | 2.56470480 |
| 149 | cytolysis (GO:0019835) | 2.56155197 |
| 150 | protein-lipid complex assembly (GO:0065005) | 2.56005851 |
| 151 | modulation by symbiont of host cellular process (GO:0044068) | 2.55725661 |
| 152 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.55558163 |
| 153 | positive regulation of cholesterol efflux (GO:0010875) | 2.54998034 |
| 154 | positive regulation of phagocytosis (GO:0050766) | 2.54140719 |
| 155 | positive regulation of cholesterol transport (GO:0032376) | 2.53127739 |
| 156 | positive regulation of sterol transport (GO:0032373) | 2.53127739 |
| 157 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.51902992 |
| 158 | definitive hemopoiesis (GO:0060216) | 2.50902282 |
| 159 | pentose-phosphate shunt (GO:0006098) | 2.50306749 |
| 160 | disruption of cells of other organism (GO:0044364) | 2.49912343 |
| 161 | killing of cells of other organism (GO:0031640) | 2.49912343 |
| 162 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.49789994 |
| 163 | protein carboxylation (GO:0018214) | 2.49505728 |
| 164 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.49505728 |
| 165 | negative regulation of cell killing (GO:0031342) | 2.49240565 |
| 166 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.49240565 |
| 167 | amino-acid betaine transport (GO:0015838) | 2.49140224 |
| 168 | carnitine transport (GO:0015879) | 2.49140224 |
| 169 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.48148088 |
| 170 | natural killer cell mediated immunity (GO:0002228) | 2.48148088 |
| 171 | peptidyl-lysine trimethylation (GO:0018023) | 2.47822611 |
| 172 | positive regulation of lipid catabolic process (GO:0050996) | 2.47792483 |
| 173 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.45790034 |
| 174 | fatty acid beta-oxidation (GO:0006635) | 2.45688826 |
| 175 | regulation of apoptotic cell clearance (GO:2000425) | 2.43954854 |
| 176 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.43258817 |
| 177 | macroautophagy (GO:0016236) | 2.43094821 |
| 178 | programmed necrotic cell death (GO:0097300) | 2.42385275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.31990679 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.14118374 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.70579066 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.44768732 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.25481147 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.24692395 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.19749367 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.09674837 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.05978599 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.04041550 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.93264469 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.69606164 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.64895366 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.62161067 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.58129734 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.55330929 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.55258793 |
| 18 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.51740890 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.45063655 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.31308082 |
| 21 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.31261115 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.29042855 |
| 23 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.20050623 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 2.14957901 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 2.12172029 |
| 26 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.08250110 |
| 27 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.04221899 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.87633801 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.82746267 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.78616449 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76371483 |
| 32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76263261 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.74682111 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.70738208 |
| 35 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.68511564 |
| 36 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.67808274 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.66723428 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.65545063 |
| 39 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.62190759 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.62101384 |
| 41 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.62091795 |
| 42 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.61691223 |
| 43 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.58264355 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.57586983 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.57072794 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.50884973 |
| 47 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.49507679 |
| 48 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.48925481 |
| 49 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48587362 |
| 50 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.47486863 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46675907 |
| 52 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.46610814 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.45602759 |
| 54 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.43216899 |
| 55 | MAF_26560356_Chip-Seq_TH1_Human | 1.42215412 |
| 56 | P68_20966046_ChIP-Seq_HELA_Human | 1.42112330 |
| 57 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.39359349 |
| 58 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.37765610 |
| 59 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.37162450 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36520820 |
| 61 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.36459492 |
| 62 | UTX_26944678_Chip-Seq_JUKART_Human | 1.35906334 |
| 63 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35852287 |
| 64 | MYB_26560356_Chip-Seq_TH1_Human | 1.35417772 |
| 65 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.34863372 |
| 66 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.31366427 |
| 67 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.30720164 |
| 68 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.30618073 |
| 69 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.29567990 |
| 70 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.29462916 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29363480 |
| 72 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.29060073 |
| 73 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.25583566 |
| 74 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.25574639 |
| 75 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.24828358 |
| 76 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.23329119 |
| 77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23176293 |
| 78 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21796587 |
| 79 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.21272142 |
| 80 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.21090315 |
| 81 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.18130244 |
| 82 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.16958355 |
| 83 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16752677 |
| 84 | KDM2B_26808549_Chip-Seq_K562_Human | 1.16663235 |
| 85 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.15345627 |
| 86 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.13345681 |
| 87 | MYB_26560356_Chip-Seq_TH2_Human | 1.12449780 |
| 88 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.12215738 |
| 89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11681671 |
| 90 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09965290 |
| 91 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09676110 |
| 92 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.09500202 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08832204 |
| 94 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.07564035 |
| 95 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07089758 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06957185 |
| 97 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06453041 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06238651 |
| 99 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.05990824 |
| 100 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05924312 |
| 101 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05134083 |
| 102 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03611692 |
| 103 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03312531 |
| 104 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03019423 |
| 105 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.02874702 |
| 106 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02075211 |
| 107 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01593262 |
| 108 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00785205 |
| 109 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00402794 |
| 110 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.99418957 |
| 111 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98884406 |
| 112 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98562112 |
| 113 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98512430 |
| 114 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98419978 |
| 115 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98129188 |
| 116 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97677494 |
| 117 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.96829859 |
| 118 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.95807018 |
| 119 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.95542242 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95125665 |
| 121 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94827138 |
| 122 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94317865 |
| 123 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93973151 |
| 124 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93656101 |
| 125 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92866278 |
| 126 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.92430101 |
| 127 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92284552 |
| 128 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.90995188 |
| 129 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.90177161 |
| 130 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87664620 |
| 131 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.86911982 |
| 132 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.86311803 |
| 133 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86100840 |
| 134 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83425783 |
| 135 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.81464167 |
| 136 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81078156 |
| 137 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80752559 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 6.44580326 |
| 2 | MP0003172_abnormal_lysosome_physiology | 3.56843124 |
| 3 | MP0005451_abnormal_body_composition | 3.31174925 |
| 4 | MP0002396_abnormal_hematopoietic_system | 3.04435235 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.04361123 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 2.73014893 |
| 7 | MP0005174_abnormal_tail_pigmentation | 2.63285171 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.47778343 |
| 9 | MP0001666_abnormal_nutrient_absorption | 2.45678027 |
| 10 | MP0003195_calcinosis | 2.43753365 |
| 11 | MP0005670_abnormal_white_adipose | 2.37503465 |
| 12 | MP0009840_abnormal_foam_cell | 2.34379487 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.30166814 |
| 14 | MP0004130_abnormal_muscle_cell | 2.28226503 |
| 15 | MP0002166_altered_tumor_susceptibility | 2.28177562 |
| 16 | MP0005360_urolithiasis | 2.25725688 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.21876477 |
| 18 | MP0005409_darkened_coat_color | 2.15799636 |
| 19 | MP0002132_abnormal_respiratory_system | 2.12241789 |
| 20 | MP0005365_abnormal_bile_salt | 2.06889130 |
| 21 | MP0005397_hematopoietic_system_phenotyp | 2.06600237 |
| 22 | MP0001545_abnormal_hematopoietic_system | 2.06600237 |
| 23 | MP0010329_abnormal_lipoprotein_level | 2.06387551 |
| 24 | MP0003122_maternal_imprinting | 2.04920904 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.00657200 |
| 26 | MP0010307_abnormal_tumor_latency | 2.00631198 |
| 27 | MP0003436_decreased_susceptibility_to | 1.99153637 |
| 28 | MP0002419_abnormal_innate_immunity | 1.89821186 |
| 29 | MP0009278_abnormal_bone_marrow | 1.79560717 |
| 30 | MP0001661_extended_life_span | 1.78712116 |
| 31 | MP0003303_peritoneal_inflammation | 1.76704520 |
| 32 | MP0000371_diluted_coat_color | 1.76397458 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.68348900 |
| 34 | MP0005076_abnormal_cell_differentiation | 1.66649371 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 1.66103063 |
| 36 | MP0003868_abnormal_feces_composition | 1.63466912 |
| 37 | MP0004808_abnormal_hematopoietic_stem | 1.60241746 |
| 38 | MP0004264_abnormal_extraembryonic_tissu | 1.56777909 |
| 39 | MP0005666_abnormal_adipose_tissue | 1.55583981 |
| 40 | MP0005075_abnormal_melanosome_morpholog | 1.52816620 |
| 41 | MP0001853_heart_inflammation | 1.50050528 |
| 42 | MP0005408_hypopigmentation | 1.49377932 |
| 43 | MP0002006_tumorigenesis | 1.46959899 |
| 44 | MP0001800_abnormal_humoral_immune | 1.43435748 |
| 45 | MP0005085_abnormal_gallbladder_physiolo | 1.40971319 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.40839723 |
| 47 | MP0003705_abnormal_hypodermis_morpholog | 1.40680132 |
| 48 | MP0003566_abnormal_cell_adhesion | 1.39952836 |
| 49 | MP0003123_paternal_imprinting | 1.38836383 |
| 50 | MP0003252_abnormal_bile_duct | 1.38226155 |
| 51 | MP0000609_abnormal_liver_physiology | 1.36980590 |
| 52 | MP0002971_abnormal_brown_adipose | 1.36941815 |
| 53 | MP0004381_abnormal_hair_follicle | 1.36201936 |
| 54 | MP0000685_abnormal_immune_system | 1.34763650 |
| 55 | MP0000015_abnormal_ear_pigmentation | 1.33595727 |
| 56 | MP0009115_abnormal_fat_cell | 1.32535615 |
| 57 | MP0002452_abnormal_antigen_presenting | 1.32339840 |
| 58 | MP0005025_abnormal_response_to | 1.29475712 |
| 59 | MP0005332_abnormal_amino_acid | 1.26803046 |
| 60 | MP0004185_abnormal_adipocyte_glucose | 1.22906821 |
| 61 | MP0009763_increased_sensitivity_to | 1.21527277 |
| 62 | MP0008260_abnormal_autophagy | 1.21013408 |
| 63 | MP0000604_amyloidosis | 1.18440365 |
| 64 | MP0002398_abnormal_bone_marrow | 1.18401905 |
| 65 | MP0008438_abnormal_cutaneous_collagen | 1.18324272 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.18111092 |
| 67 | MP0003690_abnormal_glial_cell | 1.16416701 |
| 68 | MP0002089_abnormal_postnatal_growth/wei | 1.13883916 |
| 69 | MP0003111_abnormal_nucleus_morphology | 1.11501208 |
| 70 | MP0002723_abnormal_immune_serum | 1.09746264 |
| 71 | MP0002118_abnormal_lipid_homeostasis | 1.09407437 |
| 72 | MP0005083_abnormal_biliary_tract | 1.09040424 |
| 73 | MP0001819_abnormal_immune_cell | 1.08754159 |
| 74 | MP0002420_abnormal_adaptive_immunity | 1.07815136 |
| 75 | MP0003828_pulmonary_edema | 1.07408740 |
| 76 | MP0002928_abnormal_bile_duct | 1.04822091 |
| 77 | MP0001533_abnormal_skeleton_physiology | 1.03718647 |
| 78 | MP0002722_abnormal_immune_system | 1.03550416 |
| 79 | MP0010094_abnormal_chromosome_stability | 1.02934486 |
| 80 | MP0002970_abnormal_white_adipose | 1.02740375 |
| 81 | MP0005334_abnormal_fat_pad | 1.02177008 |
| 82 | MP0004019_abnormal_vitamin_homeostasis | 1.01244264 |
| 83 | MP0000003_abnormal_adipose_tissue | 0.99917570 |
| 84 | MP0000716_abnormal_immune_system | 0.99838635 |
| 85 | MP0005000_abnormal_immune_tolerance | 0.99659648 |
| 86 | MP0008469_abnormal_protein_level | 0.99381345 |
| 87 | MP0000598_abnormal_liver_morphology | 0.99265713 |
| 88 | MP0008875_abnormal_xenobiotic_pharmacok | 0.99018388 |
| 89 | MP0002009_preneoplasia | 0.98706689 |
| 90 | MP0005319_abnormal_enzyme/_coenzyme | 0.98634333 |
| 91 | MP0000465_gastrointestinal_hemorrhage | 0.97408109 |
| 92 | MP0005375_adipose_tissue_phenotype | 0.96876690 |
| 93 | MP0009333_abnormal_splenocyte_physiolog | 0.94817235 |
| 94 | MP0003763_abnormal_thymus_physiology | 0.93964571 |
| 95 | MP0009642_abnormal_blood_homeostasis | 0.93242536 |
| 96 | MP0001764_abnormal_homeostasis | 0.93192944 |
| 97 | MP0005387_immune_system_phenotype | 0.92271973 |
| 98 | MP0001790_abnormal_immune_system | 0.92271973 |
| 99 | MP0002429_abnormal_blood_cell | 0.92191543 |
| 100 | MP0000678_abnormal_parathyroid_gland | 0.91522026 |
| 101 | MP0003724_increased_susceptibility_to | 0.89680015 |
| 102 | MP0001873_stomach_inflammation | 0.89388099 |
| 103 | MP0001915_intracranial_hemorrhage | 0.86784928 |
| 104 | MP0001986_abnormal_taste_sensitivity | 0.85457105 |
| 105 | MP0010630_abnormal_cardiac_muscle | 0.85206287 |
| 106 | MP0001845_abnormal_inflammatory_respons | 0.83876188 |
| 107 | MP0003943_abnormal_hepatobiliary_system | 0.83339032 |
| 108 | MP0000566_synostosis | 0.83156607 |
| 109 | MP0002078_abnormal_glucose_homeostasis | 0.82638384 |
| 110 | MP0009643_abnormal_urine_homeostasis | 0.80489985 |
| 111 | MP0006082_CNS_inflammation | 0.79957138 |
| 112 | MP0009785_altered_susceptibility_to | 0.79910927 |
| 113 | MP0004947_skin_inflammation | 0.79875940 |
| 114 | MP0008961_abnormal_basal_metabolism | 0.79756591 |
| 115 | MP0010352_gastrointestinal_tract_polyps | 0.78401673 |
| 116 | MP0004147_increased_porphyrin_level | 0.77648406 |
| 117 | MP0005220_abnormal_exocrine_pancreas | 0.76725046 |
| 118 | MP0004510_myositis | 0.76402669 |
| 119 | MP0002075_abnormal_coat/hair_pigmentati | 0.75911941 |
| 120 | MP0002405_respiratory_system_inflammati | 0.75624718 |
| 121 | MP0000343_altered_response_to | 0.75208378 |
| 122 | MP0000703_abnormal_thymus_morphology | 0.71746770 |
| 123 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70321069 |
| 124 | MP0000249_abnormal_blood_vessel | 0.70299197 |
| 125 | MP0002933_joint_inflammation | 0.70187951 |
| 126 | MP0010155_abnormal_intestine_physiology | 0.69899733 |
| 127 | MP0000858_altered_metastatic_potential | 0.68238427 |
| 128 | MP0001958_emphysema | 0.67380558 |
| 129 | MP0005448_abnormal_energy_balance | 0.67067861 |
| 130 | MP0003077_abnormal_cell_cycle | 0.65993869 |
| 131 | MP0003075_altered_response_to | 0.65571197 |
| 132 | MP0005671_abnormal_response_to | 0.65253550 |
| 133 | MP0008057_abnormal_DNA_replication | 0.65035620 |
| 134 | MP0009703_decreased_birth_body | 0.64131573 |
| 135 | MP0002019_abnormal_tumor_incidence | 0.63879643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 5.93189953 |
| 2 | Abnormality of the common coagulation pathway (HP:0010990) | 4.89518532 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 4.80486242 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.36742784 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.07461905 |
| 6 | Spontaneous abortion (HP:0005268) | 3.89976666 |
| 7 | Hemorrhage of the eye (HP:0011885) | 3.81096630 |
| 8 | Glomerulonephritis (HP:0000099) | 3.77277098 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.66904396 |
| 10 | Chromsome breakage (HP:0040012) | 3.64639150 |
| 11 | Abnormality of the lumbar spine (HP:0100712) | 3.58852648 |
| 12 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.46955154 |
| 13 | Abnormality of the fingertips (HP:0001211) | 3.33890869 |
| 14 | Menorrhagia (HP:0000132) | 3.26348920 |
| 15 | Hypolipoproteinemia (HP:0010981) | 3.25185035 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 3.22625522 |
| 17 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.19810588 |
| 18 | Absent frontal sinuses (HP:0002688) | 3.12629639 |
| 19 | Periodontitis (HP:0000704) | 3.09072431 |
| 20 | Abnormality of the thoracic spine (HP:0100711) | 3.01759406 |
| 21 | Prolonged bleeding time (HP:0003010) | 3.01024382 |
| 22 | Gingival bleeding (HP:0000225) | 2.98756654 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.92248233 |
| 24 | Thoracic kyphosis (HP:0002942) | 2.90877039 |
| 25 | Gastrointestinal infarctions (HP:0005244) | 2.88095424 |
| 26 | Osteomalacia (HP:0002749) | 2.86890078 |
| 27 | Acanthocytosis (HP:0001927) | 2.85357386 |
| 28 | Axonal loss (HP:0003447) | 2.79784240 |
| 29 | Joint hemorrhage (HP:0005261) | 2.77201302 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.73478558 |
| 31 | Purpura (HP:0000979) | 2.68412654 |
| 32 | Recurrent skin infections (HP:0001581) | 2.65666187 |
| 33 | Complement deficiency (HP:0004431) | 2.60587260 |
| 34 | Eczematoid dermatitis (HP:0000976) | 2.56768707 |
| 35 | Myocardial infarction (HP:0001658) | 2.55679098 |
| 36 | Autoimmune thrombocytopenia (HP:0001973) | 2.54418474 |
| 37 | Thrombophlebitis (HP:0004418) | 2.53419092 |
| 38 | Xanthomatosis (HP:0000991) | 2.53130244 |
| 39 | Flat acetabular roof (HP:0003180) | 2.50899913 |
| 40 | Hypochromic anemia (HP:0001931) | 2.48078491 |
| 41 | Hyperlipoproteinemia (HP:0010980) | 2.45128130 |
| 42 | Narrow palate (HP:0000189) | 2.44871616 |
| 43 | Epistaxis (HP:0000421) | 2.44554401 |
| 44 | Nephritis (HP:0000123) | 2.40440333 |
| 45 | Broad palm (HP:0001169) | 2.39378533 |
| 46 | Asymmetry of the thorax (HP:0001555) | 2.33697726 |
| 47 | Impaired platelet aggregation (HP:0003540) | 2.33024296 |
| 48 | Abnormal platelet function (HP:0011869) | 2.33024296 |
| 49 | Volvulus (HP:0002580) | 2.32432764 |
| 50 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.32229486 |
| 51 | Vacuolated lymphocytes (HP:0001922) | 2.31900331 |
| 52 | Long eyelashes (HP:0000527) | 2.31337272 |
| 53 | Deep venous thrombosis (HP:0002625) | 2.30585807 |
| 54 | Urethral obstruction (HP:0000796) | 2.26899626 |
| 55 | Conjugated hyperbilirubinemia (HP:0002908) | 2.25920240 |
| 56 | Recurrent fungal infections (HP:0002841) | 2.23161942 |
| 57 | Abnormality of complement system (HP:0005339) | 2.22616548 |
| 58 | Agnosia (HP:0010524) | 2.22564938 |
| 59 | Hypophosphatemic rickets (HP:0004912) | 2.20756388 |
| 60 | Pulmonary embolism (HP:0002204) | 2.20659119 |
| 61 | Neurodegeneration (HP:0002180) | 2.20581288 |
| 62 | Acute myeloid leukemia (HP:0004808) | 2.20445117 |
| 63 | Abnormal platelet volume (HP:0011876) | 2.19942997 |
| 64 | Cerebral aneurysm (HP:0004944) | 2.19125439 |
| 65 | Hypochromic microcytic anemia (HP:0004840) | 2.19029897 |
| 66 | Spondylolisthesis (HP:0003302) | 2.17724972 |
| 67 | Rickets (HP:0002748) | 2.16606445 |
| 68 | Abnormality of the intrinsic pathway (HP:0010989) | 2.16069083 |
| 69 | Abnormality of chromosome stability (HP:0003220) | 2.16046389 |
| 70 | Increased serum ferritin (HP:0003281) | 2.15475643 |
| 71 | Hepatocellular carcinoma (HP:0001402) | 2.15005982 |
| 72 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.14793458 |
| 73 | Macroorchidism (HP:0000053) | 2.13354418 |
| 74 | Gingivitis (HP:0000230) | 2.12692374 |
| 75 | Recurrent viral infections (HP:0004429) | 2.12431019 |
| 76 | Orchitis (HP:0100796) | 2.12313398 |
| 77 | Upper motor neuron abnormality (HP:0002127) | 2.12275038 |
| 78 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.10904133 |
| 79 | Myelodysplasia (HP:0002863) | 2.07169757 |
| 80 | Systemic lupus erythematosus (HP:0002725) | 2.07156998 |
| 81 | Poikilocytosis (HP:0004447) | 2.06964959 |
| 82 | Abnormality of carpal bone ossification (HP:0006257) | 2.06702452 |
| 83 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.06577761 |
| 84 | Abnormal tarsal ossification (HP:0008369) | 2.06005617 |
| 85 | Frequent falls (HP:0002359) | 2.05498637 |
| 86 | Enlarged kidneys (HP:0000105) | 2.05098678 |
| 87 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04347322 |
| 88 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.04347322 |
| 89 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.04347322 |
| 90 | Clubbing of toes (HP:0100760) | 2.04278476 |
| 91 | Intrahepatic cholestasis (HP:0001406) | 2.04249228 |
| 92 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.04113385 |
| 93 | Cellulitis (HP:0100658) | 2.02029975 |
| 94 | Epidermoid cyst (HP:0200040) | 2.01961070 |
| 95 | Osteomyelitis (HP:0002754) | 2.00613692 |
| 96 | Amyloidosis (HP:0011034) | 2.00579066 |
| 97 | Acute hepatic failure (HP:0006554) | 1.97962017 |
| 98 | Disinhibition (HP:0000734) | 1.97310758 |
| 99 | Skin nodule (HP:0200036) | 1.97033737 |
| 100 | Retrobulbar optic neuritis (HP:0100654) | 1.96880436 |
| 101 | Optic neuritis (HP:0100653) | 1.96880436 |
| 102 | High pitched voice (HP:0001620) | 1.96869003 |
| 103 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.95207891 |
| 104 | Bruising susceptibility (HP:0000978) | 1.94297829 |
| 105 | Hematochezia (HP:0002573) | 1.94219758 |
| 106 | Hypoplasia of the thymus (HP:0000778) | 1.94002090 |
| 107 | Thickened calvaria (HP:0002684) | 1.93973617 |
| 108 | Abnormality of glycolipid metabolism (HP:0010969) | 1.91379738 |
| 109 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.91379738 |
| 110 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.91379738 |
| 111 | Increased mean platelet volume (HP:0011877) | 1.91178306 |
| 112 | Abnormality of the peritoneum (HP:0002585) | 1.89965307 |
| 113 | Abnormality of the nasal septum (HP:0000419) | 1.89907159 |
| 114 | Mitral stenosis (HP:0001718) | 1.87531446 |
| 115 | Broad alveolar ridges (HP:0000187) | 1.86996288 |
| 116 | Flared metaphyses (HP:0003015) | 1.86509796 |
| 117 | Heterotopia (HP:0002282) | 1.86300059 |
| 118 | Loss of speech (HP:0002371) | 1.85978079 |
| 119 | Pathologic fracture (HP:0002756) | 1.85871501 |
| 120 | Prominent nose (HP:0000448) | 1.85639688 |
| 121 | Abnormality of macrophages (HP:0004311) | 1.84893291 |
| 122 | Thin bony cortex (HP:0002753) | 1.84697333 |
| 123 | Hypoalphalipoproteinemia (HP:0003233) | 1.84050070 |
| 124 | Spontaneous hematomas (HP:0007420) | 1.83206801 |
| 125 | Leukopenia (HP:0001882) | 1.83115071 |
| 126 | Chronic otitis media (HP:0000389) | 1.82361941 |
| 127 | Mucopolysacchariduria (HP:0008155) | 1.81927843 |
| 128 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.81927843 |
| 129 | Vascular calcification (HP:0004934) | 1.81720760 |
| 130 | Abnormality of the frontal sinuses (HP:0002687) | 1.81679892 |
| 131 | Reticulocytosis (HP:0001923) | 1.81183432 |
| 132 | * Hypercholesterolemia (HP:0003124) | 1.79798770 |
| 133 | Fat malabsorption (HP:0002630) | 1.79399332 |
| 134 | Gastrointestinal inflammation (HP:0004386) | 1.78999789 |
| 135 | Facial hemangioma (HP:0000329) | 1.78592506 |
| 136 | Dysostosis multiplex (HP:0000943) | 1.78115407 |
| 137 | Seborrheic dermatitis (HP:0001051) | 1.77444985 |
| 138 | Polycythemia (HP:0001901) | 1.77285644 |
| 139 | Albinism (HP:0001022) | 1.77179574 |
| 140 | Peritonitis (HP:0002586) | 1.76642339 |
| 141 | Vaginal fistula (HP:0004320) | 1.76620982 |
| 142 | Mediastinal lymphadenopathy (HP:0100721) | 1.75463889 |
| 143 | Global brain atrophy (HP:0002283) | 1.74628192 |
| 144 | Hepatoblastoma (HP:0002884) | 1.74219361 |
| 145 | Arterial thrombosis (HP:0004420) | 1.74020355 |
| 146 | Osteolytic defects of the hand bones (HP:0009699) | 1.71555586 |
| 147 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.71555586 |
| 148 | Abnormality of iron homeostasis (HP:0011031) | 1.71370760 |
| 149 | Syringomyelia (HP:0003396) | 1.71327885 |
| 150 | Spinal cord lesions (HP:0100561) | 1.71327885 |
| 151 | Joint swelling (HP:0001386) | 1.70715529 |
| 152 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.70434766 |
| 153 | Low anterior hairline (HP:0000294) | 1.69659512 |
| 154 | Colitis (HP:0002583) | 1.69621115 |
| 155 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.69418201 |
| 156 | Myositis (HP:0100614) | 1.69065876 |
| 157 | Widely patent fontanelles and sutures (HP:0004492) | 1.68145932 |
| 158 | Increased IgE level (HP:0003212) | 1.67865995 |
| 159 | Chronic obstructive pulmonary disease (HP:0006510) | 1.67544948 |
| 160 | Obstructive lung disease (HP:0006536) | 1.67544948 |
| 161 | Coarse hair (HP:0002208) | 1.65214523 |
| 162 | Inflammation of the large intestine (HP:0002037) | 1.65063670 |
| 163 | Capillary hemangiomas (HP:0005306) | 1.63435976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 3.82628233 |
| 2 | FGFR4 | 3.82616833 |
| 3 | ICK | 3.30675112 |
| 4 | CAMK1G | 3.14146006 |
| 5 | MAP2K3 | 2.75958274 |
| 6 | KIT | 2.69918177 |
| 7 | TAOK3 | 2.66801531 |
| 8 | CDK12 | 2.26804800 |
| 9 | PRPF4B | 2.10266904 |
| 10 | PKN2 | 2.01002144 |
| 11 | NEK2 | 1.99968989 |
| 12 | MAP4K1 | 1.97279416 |
| 13 | SIK1 | 1.96697647 |
| 14 | MAP3K10 | 1.92572477 |
| 15 | TRIB3 | 1.91634022 |
| 16 | TYK2 | 1.81862800 |
| 17 | SMG1 | 1.80408449 |
| 18 | PTK6 | 1.73597772 |
| 19 | TTN | 1.72836011 |
| 20 | CSF1R | 1.67565759 |
| 21 | BLK | 1.67233940 |
| 22 | MAP3K13 | 1.65673202 |
| 23 | WNK4 | 1.62228781 |
| 24 | CDK6 | 1.60871638 |
| 25 | FGFR3 | 1.60404429 |
| 26 | WNK1 | 1.52955883 |
| 27 | RIPK4 | 1.48467720 |
| 28 | TNK2 | 1.43749303 |
| 29 | RIPK1 | 1.41986029 |
| 30 | BTK | 1.40092569 |
| 31 | RET | 1.38392535 |
| 32 | EEF2K | 1.36473111 |
| 33 | JAK1 | 1.36418128 |
| 34 | ERN1 | 1.35561997 |
| 35 | FLT3 | 1.33943716 |
| 36 | CDC7 | 1.31435826 |
| 37 | SIK2 | 1.28183807 |
| 38 | MAPK11 | 1.21262904 |
| 39 | FGR | 1.17993689 |
| 40 | CDC42BPA | 1.15781242 |
| 41 | CDK4 | 1.14554539 |
| 42 | MAP3K2 | 1.13526844 |
| 43 | PIK3CG | 1.12684594 |
| 44 | TEC | 1.11006500 |
| 45 | IRAK4 | 1.10147348 |
| 46 | ATR | 1.04402564 |
| 47 | JAK3 | 1.04347444 |
| 48 | STK4 | 1.04084055 |
| 49 | MAP3K6 | 1.03976710 |
| 50 | MAP3K1 | 1.03617214 |
| 51 | TBK1 | 1.03304746 |
| 52 | MAP2K6 | 1.03179497 |
| 53 | TGFBR2 | 1.02566690 |
| 54 | SCYL2 | 1.02072759 |
| 55 | HCK | 1.02045827 |
| 56 | STK3 | 1.00240601 |
| 57 | FES | 0.99844689 |
| 58 | BRD4 | 0.99706145 |
| 59 | TAOK2 | 0.98220933 |
| 60 | JAK2 | 0.97807147 |
| 61 | MTOR | 0.97710388 |
| 62 | FGFR2 | 0.95562134 |
| 63 | PRKAA2 | 0.94189975 |
| 64 | MAP3K7 | 0.90646671 |
| 65 | SYK | 0.85172990 |
| 66 | TYRO3 | 0.85015475 |
| 67 | KSR2 | 0.84760387 |
| 68 | AKT3 | 0.83683725 |
| 69 | PDK2 | 0.82395955 |
| 70 | CDK9 | 0.82015249 |
| 71 | TAOK1 | 0.82011669 |
| 72 | DAPK2 | 0.81418876 |
| 73 | BRSK2 | 0.78511413 |
| 74 | PRKD2 | 0.77303218 |
| 75 | PIM1 | 0.75914864 |
| 76 | MAP3K14 | 0.75908952 |
| 77 | STK10 | 0.75118940 |
| 78 | TTK | 0.74743465 |
| 79 | NLK | 0.74014594 |
| 80 | EPHB1 | 0.73676836 |
| 81 | BCKDK | 0.72924111 |
| 82 | PDGFRA | 0.72767838 |
| 83 | BMX | 0.72459152 |
| 84 | RPS6KC1 | 0.72307143 |
| 85 | RPS6KL1 | 0.72307143 |
| 86 | PIM2 | 0.71829051 |
| 87 | CAMK4 | 0.71379816 |
| 88 | ITK | 0.71285618 |
| 89 | RPS6KA6 | 0.71184829 |
| 90 | PIK3CA | 0.71034393 |
| 91 | MATK | 0.70153971 |
| 92 | IKBKE | 0.68175180 |
| 93 | TRPM7 | 0.67113916 |
| 94 | SGK3 | 0.65713451 |
| 95 | LYN | 0.65442208 |
| 96 | MAP3K11 | 0.64925218 |
| 97 | MELK | 0.64925014 |
| 98 | MAP3K3 | 0.63582207 |
| 99 | MARK3 | 0.63150311 |
| 100 | ZAP70 | 0.62769615 |
| 101 | HIPK2 | 0.62713040 |
| 102 | IRAK3 | 0.62658836 |
| 103 | LCK | 0.61108579 |
| 104 | RPS6KB1 | 0.61087423 |
| 105 | RPS6KA4 | 0.60924937 |
| 106 | MAP3K5 | 0.59972244 |
| 107 | PDGFRB | 0.58834323 |
| 108 | DMPK | 0.57813242 |
| 109 | MARK2 | 0.57147553 |
| 110 | IKBKB | 0.56676175 |
| 111 | PDK1 | 0.55909170 |
| 112 | PAK4 | 0.54358919 |
| 113 | CHUK | 0.53925842 |
| 114 | CSK | 0.53597241 |
| 115 | PDPK1 | 0.50873280 |
| 116 | NEK9 | 0.50578473 |
| 117 | RPS6KB2 | 0.48693284 |
| 118 | EIF2AK1 | 0.48121349 |
| 119 | PRKAA1 | 0.46463267 |
| 120 | YES1 | 0.46427418 |
| 121 | CDK7 | 0.43671873 |
| 122 | MAP2K2 | 0.42775527 |
| 123 | FGFR1 | 0.42588950 |
| 124 | RPS6KA1 | 0.42135026 |
| 125 | ATM | 0.41587598 |
| 126 | MAPK12 | 0.41503939 |
| 127 | AKT1 | 0.41496886 |
| 128 | MAPK7 | 0.40850060 |
| 129 | MAP3K8 | 0.40642562 |
| 130 | EIF2AK2 | 0.40150866 |
| 131 | SGK1 | 0.40107131 |
| 132 | GRK6 | 0.39852865 |
| 133 | RPS6KA2 | 0.39247834 |
| 134 | SGK2 | 0.39136201 |
| 135 | PLK4 | 0.38409502 |
| 136 | EGFR | 0.37287752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.33028413 |
| 2 | Lysine degradation_Homo sapiens_hsa00310 | 2.51872879 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.43041686 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.39153264 |
| 5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.24263643 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.23201933 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.22519691 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.09396411 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.99161129 |
| 10 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.92898637 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.90711556 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.85738421 |
| 13 | ABC transporters_Homo sapiens_hsa02010 | 1.85262541 |
| 14 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.60047876 |
| 15 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.57842156 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.56176590 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.52378161 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.41877412 |
| 19 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.36873816 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.35987277 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.35320918 |
| 22 | DNA replication_Homo sapiens_hsa03030 | 1.35095620 |
| 23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.31723177 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.31276584 |
| 25 | Insulin resistance_Homo sapiens_hsa04931 | 1.31163815 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.30157681 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.28413730 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.26283260 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.26070881 |
| 30 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.24664538 |
| 31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.21151251 |
| 32 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.20244472 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.18491576 |
| 34 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.16573541 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.16315682 |
| 36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16288575 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.15196368 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.14768515 |
| 39 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.14247777 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.13233807 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.12704572 |
| 42 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.12446560 |
| 43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.11963592 |
| 44 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.07938191 |
| 45 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.06988144 |
| 46 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.06945772 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.06691856 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.06508487 |
| 49 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.03559781 |
| 50 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.02159092 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 1.01727289 |
| 52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.01368270 |
| 53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.00997962 |
| 54 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.98456906 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96244656 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.95986979 |
| 57 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.95983429 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95313775 |
| 59 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.95284981 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.92833380 |
| 61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.92806507 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.92537814 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92182319 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.91893842 |
| 65 | Mismatch repair_Homo sapiens_hsa03430 | 0.88571577 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.86952335 |
| 67 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.86741877 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.85306814 |
| 69 | Influenza A_Homo sapiens_hsa05164 | 0.85090485 |
| 70 | Tuberculosis_Homo sapiens_hsa05152 | 0.83921405 |
| 71 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.82991321 |
| 72 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.81917478 |
| 73 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.80980947 |
| 74 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.80348425 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79183139 |
| 76 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79120463 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78244147 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.77353982 |
| 79 | Apoptosis_Homo sapiens_hsa04210 | 0.77325813 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77164929 |
| 81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77062828 |
| 82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.76805266 |
| 83 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.76525688 |
| 84 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.75797230 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.75391507 |
| 86 | Measles_Homo sapiens_hsa05162 | 0.75244000 |
| 87 | Base excision repair_Homo sapiens_hsa03410 | 0.74433823 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.73814453 |
| 89 | Sulfur relay system_Homo sapiens_hsa04122 | 0.70735261 |
| 90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70656619 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70188590 |
| 92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66770331 |
| 93 | Malaria_Homo sapiens_hsa05144 | 0.66329674 |
| 94 | Hepatitis B_Homo sapiens_hsa05161 | 0.66271160 |
| 95 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.65716345 |
| 96 | Pertussis_Homo sapiens_hsa05133 | 0.65436498 |
| 97 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65073389 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64003032 |
| 99 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62850455 |
| 100 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.60948911 |
| 101 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.59907457 |
| 102 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.59825014 |
| 103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59463605 |
| 104 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58439843 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58297529 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58098093 |
| 107 | Homologous recombination_Homo sapiens_hsa03440 | 0.58091515 |
| 108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57636191 |
| 109 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.57415538 |
| 110 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57298815 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57085471 |
| 112 | Hepatitis C_Homo sapiens_hsa05160 | 0.55930371 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.55009911 |
| 114 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54804415 |
| 115 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50709775 |
| 116 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.50707951 |
| 117 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49017708 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48791412 |
| 119 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48620960 |
| 120 | Cell cycle_Homo sapiens_hsa04110 | 0.48408095 |
| 121 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48089543 |
| 122 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47076014 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46247007 |
| 124 | Legionellosis_Homo sapiens_hsa05134 | 0.45233044 |
| 125 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44927535 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43015524 |
| 127 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.42220606 |
| 128 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42201238 |
| 129 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41717873 |
| 130 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.41340267 |
| 131 | Thyroid cancer_Homo sapiens_hsa05216 | 0.41210359 |
| 132 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40821257 |
| 133 | Amoebiasis_Homo sapiens_hsa05146 | 0.40231256 |
| 134 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.40189231 |

